KR101101321B1 - 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 - Google Patents
상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 Download PDFInfo
- Publication number
- KR101101321B1 KR101101321B1 KR1020080108458A KR20080108458A KR101101321B1 KR 101101321 B1 KR101101321 B1 KR 101101321B1 KR 1020080108458 A KR1020080108458 A KR 1020080108458A KR 20080108458 A KR20080108458 A KR 20080108458A KR 101101321 B1 KR101101321 B1 KR 101101321B1
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- hydrogel
- composition
- vehicle composition
- cell delivery
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Abstract
Description
Claims (11)
- 생리식염수, 인산완충용액(PBS), 및 세포배양배지로 이루어진 군으로부터 선택된 수성 매질에 겔란트(gellant)없이 비이온성 계면활성제인 폴리프로필렌글리콜폴리에틸렌글리콜 축합물이 15~50%의 중량비로 혼합되어 분산되어 구성된 하이드로겔 형태를 갖는 세포 전달(delivery)용 비히클 조성물.
- 삭제
- 삭제
- 제 1항에 있어서, 상기 비이온성 계면활성제인 폴리프로필렌글리콜폴리에틸렌글리콜 축합물은 폴록사머(Poloxamer)인 것을 특징으로 하는 세포 전달용 비히클 조성물.
- 삭제
- 제 1항에 있어서, 상기 하이드로겔은 상처치유를 돕는 염기성섬유아세포성장인자(bFGF: basic Fibroblast Growth Factor), 표피성장인자(EGF: Epidermal Growth Factor), 및 과립구대식세포집락자극이자(GMCSF: Granulocyte Macrophage Colony-Stimulating Factor)로 이루어진 군에서 선택된 성장인자 또는 물질-P (Substance-P)를 더 포함하는 것을 특징으로 세포 전달용 비히클 조성물.
- 제 1항에 있어서, 상기 하이드로겔은 상처치유를 돕는 콜라겐(Collagen), 히알루론산(Hyaluronic acid), 글루코스아미노글리칸(Glycosaminoglycanes), 파이브로넥틴(Fibronectin) 또는 이들의 혼합물로 이루어진 군에서 선택된 세포 간물질(ECM)을 더 포함하는 것을 특징으로 세포 전달용 비히클 조성물.
- 삭제
- 제 1항에 있어서, 상기 하이드로겔은 세포를 더 포함하는 것을 특징으로 하는 세포 전달용 비히클 조성물.
- 제 1항에 있어서, 상기 세포는 피부각질세포, 섬유아세포, 색소세포, 중배엽 줄기세포, 간엽줄기세포, 조혈모세포, 골수세포, 신경세포, 상피세포 또는 이들의 혼합물로 이루어지는 군으로부터 선택된 것을 특징으로 하는 세포 전달용 비히클 조성물.
- 제 1항에 있어서, 상기 세포 전달은 상처 치유를 위한 것을 특징으로 하는 세포 전달용 비히클 조성물.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080108458A KR101101321B1 (ko) | 2008-11-03 | 2008-11-03 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
JP2011534402A JP2012507510A (ja) | 2008-11-03 | 2009-11-03 | 傷の治癒のためのハイドロゲル状の細胞伝達用ビヒクル及びその製造方法 |
CN2009801434363A CN102307596A (zh) | 2008-11-03 | 2009-11-03 | 伤口愈合用水凝胶细胞传送载体及其制备方法 |
US13/127,165 US20110256089A1 (en) | 2008-11-03 | 2009-11-03 | Hydrogel Type Cell Delivery Vehicle for Wound Healing, and Preparation Method Thereof |
PCT/KR2009/006425 WO2010062059A2 (ko) | 2008-11-03 | 2009-11-03 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080108458A KR101101321B1 (ko) | 2008-11-03 | 2008-11-03 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100049341A KR20100049341A (ko) | 2010-05-12 |
KR101101321B1 true KR101101321B1 (ko) | 2012-01-02 |
Family
ID=42226214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080108458A KR101101321B1 (ko) | 2008-11-03 | 2008-11-03 | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20110256089A1 (ko) |
JP (1) | JP2012507510A (ko) |
KR (1) | KR101101321B1 (ko) |
CN (1) | CN102307596A (ko) |
WO (1) | WO2010062059A2 (ko) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015105249A1 (ko) | 2014-01-10 | 2015-07-16 | (주)안트로젠 | 피부 재생 또는 상처 치유를 위한 중간엽 줄기세포-하이드로겔-생분해성또는중간엽 줄기세포-하이드로겔-비분해성 지지체 조성물 |
WO2018097527A1 (ko) * | 2016-11-25 | 2018-05-31 | 아주대학교산학협력단 | 액상 플라즈마를 포함하는 피부미백 또는 상처치료용 조성물 |
KR20180059341A (ko) * | 2016-11-25 | 2018-06-04 | 아주대학교산학협력단 | 액상 플라즈마를 포함하는 상처 치료용 조성물 |
WO2019099860A3 (en) * | 2017-11-17 | 2019-06-27 | Medline Industries, Inc. | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing |
US11246885B2 (en) | 2017-08-31 | 2022-02-15 | Ajou University Industry-Academic Cooperation Foundation | Keloid prevention or treatment method using liquid phase plasma |
US11510853B2 (en) | 2017-09-18 | 2022-11-29 | Ajou University Industry-Academic Cooperation Foundation | Composition for skin soothing containing liquid-phase plasma |
US11759407B2 (en) | 2016-11-25 | 2023-09-19 | Ajou Univ. Industry-Academic Cooperation Found. | Composition for skin whitening or wound treatment, containing liquid plasma |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8202701B2 (en) | 2004-10-08 | 2012-06-19 | Georgia Tech Research Corporation | Microencapsulation of cells in hydrogels using electrostatic potentials |
KR101240133B1 (ko) * | 2011-01-27 | 2013-03-11 | 서울대학교산학협력단 | 히알루론산과 알지네이트를 포함하는 상호관입고분자망목 구조의 세포전달용 지지체의 제조방법 |
EP3013377B1 (en) * | 2013-06-27 | 2020-08-05 | Regentis Biomaterials Ltd. | Compositions comprising a polymer-protein conjugate and an environmentally-responsive polymer and uses thereof |
CN103550830A (zh) * | 2013-10-15 | 2014-02-05 | 北京大学 | 一种海藻酸-透明质酸原位组织工程细胞支架及其制备方法 |
CL2013003066A1 (es) | 2013-10-22 | 2014-07-25 | Univ Chile | Composicion para tratamiento de heridas porque comprende matriz soporte y células troncalesmesenquiámicas de gelatina de wharton; metodo para tratar heridas que comprende aplicar dicha composicion |
CN104888669A (zh) * | 2014-03-05 | 2015-09-09 | 中国科学院苏州纳米技术与纳米仿生研究所 | 一种彩色水凝胶及其制备方法 |
CN105622961B (zh) * | 2016-03-15 | 2018-02-23 | 东华大学 | 一种自愈性多糖水凝胶的制备方法 |
KR101825041B1 (ko) * | 2016-04-07 | 2018-02-02 | 주식회사 바이오솔루션 | 물질 p를 포함하는 상처치유용 약학 조성물 |
CN105968390A (zh) * | 2016-07-11 | 2016-09-28 | 武汉大学 | 一种壳聚糖基自愈合凝胶及其制备方法 |
KR102168094B1 (ko) | 2018-10-02 | 2020-10-20 | 한국과학기술연구원 | 하이드로겔 조성물 및 그를 포함하는 바이오 잉크 조성물 |
CN111249520A (zh) * | 2020-01-17 | 2020-06-09 | 中山大学孙逸仙纪念医院 | 一种装载小干扰rna纳米粒的复合水凝胶敷料及其制备方法 |
CN115389365B (zh) * | 2022-10-31 | 2023-01-24 | 北京大学口腔医学院 | 用于评价超分子水凝胶载体的性能的方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333194B1 (en) | 1999-01-19 | 2001-12-25 | The Children's Hospital Of Philadelphia | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
US7083806B2 (en) * | 2000-05-08 | 2006-08-01 | Maelor Pharmaceuticals Limited | Wound gels |
KR20070076742A (ko) * | 2006-01-19 | 2007-07-25 | 서울산업대학교 산학협력단 | 키토산 또는 히알루론산-폴리에틸렌옥사이드 및키토산-히알루론산-폴리에틸렌옥사이드를 기저로 하는하이드로젤과 이의 제조방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0386960A3 (en) * | 1989-03-07 | 1991-10-23 | American Cyanamid Company | Pharmaceutical compositions useful as drug delivery vehicles and/or as wound dressings |
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
ATE250928T1 (de) * | 1995-07-12 | 2003-10-15 | Cygnus Therapeutic Systems | Hydrogelpflaster |
WO1997017038A1 (en) * | 1995-11-09 | 1997-05-15 | University Of Massachusetts | Tissue re-surfacing with hydrogel-cell compositions |
US6171610B1 (en) * | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
AU758178B2 (en) * | 1998-09-04 | 2003-03-20 | Scios Inc. | Hydrogel compositions for the controlled release administration of growth factors |
CA2489347A1 (en) * | 2002-06-20 | 2003-12-31 | Amnon Sintov | Transdermal drug delivery system |
US20040101959A1 (en) * | 2002-11-21 | 2004-05-27 | Olga Marko | Treatment of tissue with undifferentiated mesenchymal cells |
US20050079147A1 (en) * | 2003-10-14 | 2005-04-14 | Bernard Delaey | Wound healing compositions and uses |
EP2076275B1 (en) * | 2006-10-06 | 2014-12-03 | University Of Virginia Patent Foundation | Compositions useful for diabetic wound healing |
CN101181242A (zh) * | 2007-11-22 | 2008-05-21 | 沈阳药科大学 | 一种作为伤口用给药系统载体的吸水性微球及制备方法 |
-
2008
- 2008-11-03 KR KR1020080108458A patent/KR101101321B1/ko active IP Right Grant
-
2009
- 2009-11-03 WO PCT/KR2009/006425 patent/WO2010062059A2/ko active Application Filing
- 2009-11-03 JP JP2011534402A patent/JP2012507510A/ja active Pending
- 2009-11-03 US US13/127,165 patent/US20110256089A1/en not_active Abandoned
- 2009-11-03 CN CN2009801434363A patent/CN102307596A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6333194B1 (en) | 1999-01-19 | 2001-12-25 | The Children's Hospital Of Philadelphia | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
US7083806B2 (en) * | 2000-05-08 | 2006-08-01 | Maelor Pharmaceuticals Limited | Wound gels |
KR20070076742A (ko) * | 2006-01-19 | 2007-07-25 | 서울산업대학교 산학협력단 | 키토산 또는 히알루론산-폴리에틸렌옥사이드 및키토산-히알루론산-폴리에틸렌옥사이드를 기저로 하는하이드로젤과 이의 제조방법 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015105249A1 (ko) | 2014-01-10 | 2015-07-16 | (주)안트로젠 | 피부 재생 또는 상처 치유를 위한 중간엽 줄기세포-하이드로겔-생분해성또는중간엽 줄기세포-하이드로겔-비분해성 지지체 조성물 |
WO2018097527A1 (ko) * | 2016-11-25 | 2018-05-31 | 아주대학교산학협력단 | 액상 플라즈마를 포함하는 피부미백 또는 상처치료용 조성물 |
KR20180059341A (ko) * | 2016-11-25 | 2018-06-04 | 아주대학교산학협력단 | 액상 플라즈마를 포함하는 상처 치료용 조성물 |
KR102006784B1 (ko) * | 2016-11-25 | 2019-08-02 | 아주대학교 산학협력단 | 액상 플라즈마를 포함하는 상처 치료용 조성물 |
US11759407B2 (en) | 2016-11-25 | 2023-09-19 | Ajou Univ. Industry-Academic Cooperation Found. | Composition for skin whitening or wound treatment, containing liquid plasma |
US11246885B2 (en) | 2017-08-31 | 2022-02-15 | Ajou University Industry-Academic Cooperation Foundation | Keloid prevention or treatment method using liquid phase plasma |
US11510853B2 (en) | 2017-09-18 | 2022-11-29 | Ajou University Industry-Academic Cooperation Foundation | Composition for skin soothing containing liquid-phase plasma |
WO2019099860A3 (en) * | 2017-11-17 | 2019-06-27 | Medline Industries, Inc. | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing |
US11510969B2 (en) | 2017-11-17 | 2022-11-29 | Medline Industries, Lp | Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing |
Also Published As
Publication number | Publication date |
---|---|
US20110256089A1 (en) | 2011-10-20 |
KR20100049341A (ko) | 2010-05-12 |
JP2012507510A (ja) | 2012-03-29 |
WO2010062059A3 (ko) | 2010-08-19 |
CN102307596A (zh) | 2012-01-04 |
WO2010062059A2 (ko) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101101321B1 (ko) | 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법 | |
US11590259B2 (en) | Composition and kits for pseudoplastic microgel matrices | |
Yao et al. | Novel bilayer wound dressing based on electrospun gelatin/keratin nanofibrous mats for skin wound repair | |
Rameshbabu et al. | Polycaprolactone nanofibers functionalized with placental derived extracellular matrix for stimulating wound healing activity | |
Datta et al. | Oleoyl-chitosan-based nanofiber mats impregnated with amniotic membrane derived stem cells for accelerated full-thickness excisional wound healing | |
KR102473363B1 (ko) | 스프레이형 하이드로젤 창상 피복제 제조방법 및 이에 따른 스프레이형 하이드로젤 창상 피복제 | |
Chang et al. | An injectable aldehyded 1-amino-3, 3-diethoxy-propane hyaluronic acid–chitosan hydrogel as a carrier of adipose derived stem cells to enhance angiogenesis and promote skin regeneration | |
Hazrati et al. | Bioactive functional scaffolds for stem cells delivery in wound healing and skin regeneration | |
KR20150128481A (ko) | 세포외기질 및 온도감응성 고분자를 포함하는 생체 피부용 조성물 | |
JP2018534353A (ja) | 感染の防御を提供する軟組織増大のための組成物 | |
Xu et al. | A highly stretchable, adhesive, and antibacterial hydrogel with chitosan and tobramycin as dynamic cross-linkers for treating the infected diabetic wound | |
Rijal et al. | Biomaterials for diabetic wound-healing therapies | |
Wang et al. | Preclinical animal study of electrospun poly (l-lactide-co-caprolactone) and formulated porcine fibrinogen for full-thickness diabetic wound regeneration | |
JP2023508917A (ja) | 生体適合性材料 | |
Kim et al. | Liquid-type plasma-controlled in situ crosslinking of silk-alginate injectable gel displayed better bioactivities and mechanical properties | |
US9345723B2 (en) | Rapid formation of chitosan sponges using guanosine 5′-diphosphate: injectable scaffolds for tissue regeneration and drug delivery | |
Elyasifar et al. | Bi-layered photocrosslinkable chitosan-curcumin hydrogel/soy protein nanofibrous mat skin substitute | |
Zhang et al. | Gelatin-Based Injectable Hydrogels Loaded with Copper Ion Cross-linked Tannic Acid Nanoparticles for Irregular Wound Closure Repair | |
Lam | Mesenchymal Stem Cell Therapies for Skin Repair and Regeneration | |
Mayet | Inflammatory dependent bioresponsive smart transdermal delivery system incorporating susppended nanofibrous mats as a platform for wound healing | |
Dixit et al. | Thermoresponsive keratin-methylcellulose self-healing injectable hydrogel accelerating full-thickness wound healing by promoting rapid epithelialization | |
ter Horst | A gellan-based fluid gel carrier for spray delivery | |
Sivagnanam | Dual-layered 3D nanofibrous matrix incorporated with dual drugs and their synergetic effect on accelerating wound healing through growth factor regulation | |
Witte | Hyaluronan and its application in equine lower limb wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20150106 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20151106 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20161017 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20171206 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20181105 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20191107 Year of fee payment: 9 |